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DICLOXACILLIN （SP－125） ・FOR URINARY ・TRACT INFECTIONS
Hikohachiro’INouE， Tdru MissE， Mitsuo MiyAGAwA and K6zi TAKAHAsHi
From the 1）ePartment’o∫こケoZo8y， Osα加Prefectural ffospital
      （Chieア’1）r． H， Inoue， M．ρ．）
  SP－125 （each 1 capsule contains 125 mg of Dicloxacillin） was applied clinically in a daily
dose of 1000 mg in 4 divided doses in various infectious conditions of the urinary tract in the
field of urology and the following resul’狽?were obtained．
  1） Out of 25 cases of urinary tract infections treated， there were 16 cases of very effective，
7cases of effectiye and 2 ineffective cases， sp a rate of effectiveness was 92 ％． This rate of
effectiveness， howevcr， was obtained in acute infections and the same effectiveness cannot・be
．expected in chronic infections． The results in chronic ptostqtitis and seminal vesiculitis verify’
this一．
  2） The effect of the agent against the organisms isolated from the cases was’ examined，
It was extre血ely efEective against cocci but ineffective against baごilli． It was found that infec－
tion by bacilli developed during treatment and this can be considered a natural phenomenon ih’
view Of the antibacterial spectrum of the agent． Measures to prevent this musゆe taken． In
our cases， other agents which act against bacilli are give’?concomitantly．















































































   R， R’ ＝＝H ： Oxacillin
   R＝Cl， R’＝H ： Cloxacillin


























































































   球菌の消失
   球菌消失するも桿菌出現
   球菌消失するも些些球菌出現



























         非淋菌性
（d）性器系感染例
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